Literature DB >> 11807615

Is quantitation necessary for oncological PET studies? For.

R Edward Coleman1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11807615     DOI： 10.1007/s00259-001-0679-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  6 in total

1.  Prospective investigation of positron emission tomography in lung nodules.

Authors:  V J Lowe; J W Fletcher; L Gobar; M Lawson; P Kirchner; P Valk; J Karis; K Hubner; D Delbeke; E V Heiberg; E F Patz; R E Coleman
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

2.  Pulmonary abnormalities and PET data analysis: a retrospective study.

Authors:  V J Lowe; F G Duhaylongsod; E F Patz; D M Delong; J M Hoffman; W G Wolfe; R E Coleman
Journal:  Radiology       Date:  1997-02       Impact factor: 11.105

3.  Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities.

Authors:  V J Lowe; J M Hoffman; D M DeLong; E F Patz; R E Coleman
Journal:  J Nucl Med       Date:  1994-11       Impact factor: 10.057

4.  The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma.

Authors:  V Ahuja; R E Coleman; J Herndon; E F Patz
Journal:  Cancer       Date:  1998-09-01       Impact factor: 6.860

5.  Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

Authors:  Steven M. Larson; Yusuf Erdi; Timothy Akhurst; Madhu Mazumdar; Homer A. Macapinlac; Ronald D. Finn; Cecille Casilla; Melissa Fazzari; Neil Srivastava; Henry W.D. Yeung; John L. Humm; Jose Guillem; Robert Downey; Martin Karpeh; Alfred E. Cohen; Robert Ginsberg
Journal:  Clin Positron Imaging       Date:  1999-05

6.  Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography.

Authors:  F G Duhaylongsod; V J Lowe; E F Patz; A L Vaughn; R E Coleman; W G Wolfe
Journal:  Ann Thorac Surg       Date:  1995-11       Impact factor: 4.330
  6 in total
  11 in total

Review 1.  Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography.

Authors:  Craig K Abbey; Alexander D Borowsky; Jeffery P Gregg; Robert D Cardiff; Simon R Cherry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-04       Impact factor: 2.673

2.  A hybrid algorithm for PET/CT image merger in hybrid scanners.

Authors:  John A Kennedy; Ora Israel; Alex Frenkel; Rachel Bar-Shalom; Haim Azhari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-10       Impact factor: 9.236

3.  Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.

Authors:  Carryn M Anderson; Tangel Chang; Michael M Graham; Michael D Marquardt; Anna Button; Brian J Smith; Yusuf Menda; Wenqing Sun; Nitin A Pagedar; John M Buatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-01-30       Impact factor: 7.038

4.  Quantifying and reducing the effect of calibration error on variability of PET/CT standardized uptake value measurements.

Authors:  Catherine M Lockhart; Lawrence R MacDonald; Adam M Alessio; Wendy A McDougald; Robert K Doot; Paul E Kinahan
Journal:  J Nucl Med       Date:  2011-01-13       Impact factor: 10.057

Review 5.  Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy.

Authors:  Paul E Kinahan; James W Fletcher
Journal:  Semin Ultrasound CT MR       Date:  2010-12       Impact factor: 1.875

Review 6.  Advantages and limitations of FDG PET in the follow-up of breast cancer.

Authors:  Peter Lind; Isabel Igerc; Thomas Beyer; Peter Reinprecht; Klaus Hausegger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-15       Impact factor: 9.236

7.  PET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data, and Error.

Authors:  Paul E Kinahan; Robert K Doot; Michelle Wanner-Roybal; Luc M Bidaut; Samuel G Armato; Charles R Meyer; Geoffrey McLennan
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

8.  Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings.

Authors:  Virendra Kumar; Kavindra Nath; Claudia G Berman; Jongphil Kim; Tawee Tanvetyanon; Alberto A Chiappori; Robert A Gatenby; Robert J Gillies; Edward A Eikman
Journal:  Clin Nucl Med       Date:  2013-03       Impact factor: 7.794

9.  Quantitative Assessment of Radionuclide Uptake and Positron Emission Tomography-computed Tomography Image Contrast.

Authors:  Hasford Francis; John Humphrey Amuasi; Kyere Augustine Kwame; Mboyo Di Tamba Vangu
Journal:  World J Nucl Med       Date:  2016-09

10.  The reduction of artifacts due to metal hip implants in CT-attenuation corrected PET images from hybrid PET/CT scanners.

Authors:  John A Kennedy; Ora Israel; Alex Frenkel; Rachel Bar-Shalom; Haim Azhari
Journal:  Med Biol Eng Comput       Date:  2007-05-23       Impact factor: 3.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.